Genomics of Adverse Drug Reactions

被引：45

作者：

Alfirevic, Ana ^{[1
]}

Pirmohamed, Munir ^{[1
]}

机构：

[1] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Block A Waterhouse Bldg,1-5 Brownlow St, Liverpool L69 3GL, Merseyside, England

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 2017年 / 38卷 / 01期

基金：

英国医学研究理事会; 欧盟地平线“2020”; 美国国家卫生研究院;

关键词：

INDUCED LIVER-INJURY; IMPLEMENTATION CONSORTIUM GUIDELINES; HLA-B GENOTYPE; HUMAN-LEUKOCYTE ANTIGEN-B-ASTERISK-5701; ANTHRACYCLINE-INDUCED CARDIOTOXICITY; ABACAVIR HYPERSENSITIVITY; IMPAIRED OXIDATION; PEPTIDE REPERTOIRE; PRECISION MEDICINE; COST-EFFECTIVENESS;

D O I：

10.1016/j.tips.2016.11.003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Adverse drug reactions (ADRs) are common, are associated with morbidity and mortality, and are costly to healthcare systems. Genomic factors predispose to ADRs, but these vary depending on the drug, patient, and disease. Genomic testing can not only help to predict and prevent ADRs but can also be used in other ways (diagnosis, closer monitoring of those at risk, pre-emptive genotyping, and understanding of mechanism), all of which will be important in the future to improve the benefit-risk ratio of drugs. In the era of precision medicine, such genomic data will need to be integrated with other forms of data to develop a comprehensive and integrated approach to improve responses to medicines used in patients.

引用

页码：100 / 109

页数：10

共 79 条

[51] Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients [J].

Pirmohamed, M ;

James, S ;

Meakin, S ;

Green, C ;

Scott, AK ;

Walley, TJ ;

Farrar, K ;

Park, BK ;

Breckenridge, AM .

BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7456) :15-19

[52] Acceptance of Biomarker-Based Tests for Application in Clinical Practice: Criteria and Obstacles [J].

Pirmohamed, M. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (06) :862-866

[53] New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity [J].

Pirmohamed, Munir ;

Ostrov, David A. ;

Park, B. Kevin .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (02) :236-244

[54] Oral anticoagulation: a critique of recent advances and controversies [J].

Pirmohamed, Munir ;

Kamali, Farhad ;

Daly, Ann K. ;

Wadelius, Mia .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2015, 36 (03) :153-163

[55] Personalized Pharmacogenomics: Predicting Efficacy and Adverse Drug Reactions [J].

Pirmohamed, Munir .

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 15, 2014, 15 :349-370

[56] A Randomized Trial of Genotype-Guided Dosing of Warfarin [J].

Pirmohamed, Munir ;

Burnside, Girvan ;

Eriksson, Niclas ;

Jorgensen, Andrea L. ;

Toh, Cheng Hock ;

Nicholson, Toby ;

Kesteven, Patrick ;

Christersson, Christina ;

Wahlstrom, Bengt ;

Stafberg, Christina ;

Zhang, J. Eunice ;

Leathart, Julian B. ;

Kohnke, Hugo ;

Maitland-van der Zee, Anke H. ;

Williamson, Paula R. ;

Daly, Ann K. ;

Avery, Peter ;

Kamali, Farhad ;

Wadelius, Mia .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (24) :2294-2303

[57] A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions [J].

Plumpton, Catrin O. ;

Roberts, Daniel ;

Pirmohamed, Munir ;

Hughes, Dyfrig A. .

PHARMACOECONOMICS, 2016, 34 (08) :771-793

[58]

Rao US, 2015, PHARMACOGENOMICS, V16, P905, DOI [10.2217/pgs.15.50, 10.2217/PGS.15.50]

[59] Drug Discontinuation Effects Are Part of the Pharmacology of a Drug [J].

Reidenberg, Marcus M. .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (02) :324-328

[60] Pharmacogenomics in the clinic [J].

Relling, Mary V. ;

Evans, William E. .

NATURE, 2015, 526 (7573) :343-350

← 1 2 3 4 5 6 7 8 →